Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Certain genes are linked to the quality of cashmere in goats.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Online articles about alopecia areata are too hard to understand and need to be clearer.

The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

AI and AR are improving cosmetic dermatology but face challenges like data quality and ethical concerns.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Early genetic testing and zinc therapy are crucial for managing acrodermatitis enteropathica effectively.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

Certain gene variations might be linked to severe acne in women but not in men.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

AI is transforming healthcare by improving diagnostics and therapy, despite challenges with data and trust.

Amino acids in conditioners improve hair strength, hydration, and color retention.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

AI improves cosmetic surgery but requires ethical and legal oversight to ensure safe use.

Unable to summarize document.

DALL-E 2 is only accurate for acne in pediatric dermatology and needs better data for other conditions.